查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585656

生物製药发酵系统市场：按产品、应用和最终用户划分 - 全球预测 2025-2030

Biopharmaceutical Fermentation System Market by Product (Downstream Process Product, Upstream Process Product), Application (Antibiotics, Monoclonal Antibodies, Probiotics), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物製药发酵系统市值为156.5亿美元，预计2024年将达到168.6亿美元，复合年增长率为7.82%，预计到2030年将达到265.2亿美元。

生物製药发酵系统市场主要包括透过微生物和细胞发酵製程生产生物製药的技术和设备。透过促进受控微生物生长，这些系统对于大规模生产生技药品（包括疫苗、单株抗体和重组蛋白）至关重要。发酵系统在生产无法化学合成的复杂生物活性产品方面发挥关键作用，凸显了对发酵系统的需求。应用包括製药、生物技术、食品和饮料以及环境，最终用户范围从製药公司到受託製造厂商和研究机构。影响该市场的主要成长要素包括由于慢性病的增加而对生物製药的需求不断增加以及对个人化医疗的兴趣日益浓厚。生物製程设备的技术进步以及一次性系统的创新也透过提供更灵活、更具成本效益和扩充性的解决方案来推动市场成长。最新的潜在商机存在于医疗保健基础设施正在发展的新兴市场以及新型生物相似药和生技药品的开拓中市场。然而，高昂的初始资本投资、严格的监管要求和复杂的製造流程等挑战严重限制了市场扩张。需要创新的领域包括开发高效的下游加工技术、改进过程分析技术（PAT）以及透过合成生物学提高生物製药生产的效率。探索发酵过程的自动化和数数位化也为业务成长提供了途径。该市场是动态的，其特点是技术快速进步和竞争格局，主要企业在研发方面投入大量资金。随着产业转向更绿色的生物製造实践，公司可以透过专注于开发更永续和更有效率的发酵过程来利用这些趋势。

主要市场统计
基准年[2023] 156.5亿美元
预测年份 [2024] 168.6亿美元
预测年份 [2030] 265.2亿美元
复合年增长率（%） 7.82%

市场动态：快速发展的生物製药发酵系统市场的关键市场洞察

供需的动态交互作用正在改变生物製药发酵系统市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 生物製药需求不断成长
    • 慢性病增加
    • 生物基生产过程中工业测量与监控技术的发展
  • 市场限制因素
    • 与製造业相关的高成本和严格的监管要求
  • 市场机会
    • 创造高效且经济高效的发酵系统的新创新
    • 发酵技术各领域研发的活性化
  • 市场挑战
    • 缺乏对生物製药发酵系统的认识和训练有素的专业人员

波特五力：驾驭生物製药发酵系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物製药发酵系统市场的外部影响

外部宏观环境因素在塑造生物製药发酵系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物製药发酵系统市场的竞争格局

对生物製药发酵系统市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵生物製药发酵系统市场供应商绩效评估

FPNV定位矩阵是评估生物製药发酵系统市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了生物製药发酵系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生物製药发酵系统市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对生物技术药物的需求增加
      • 慢性病发生率增加
      • 生物基生产过程的工业测量和监控技术的开发
    • 抑制因素
      • 与製造业相关的高成本和严格的监管要求
    • 机会
      • 高效且经济高效的发酵系统的新创新
      • 增加发酵技术各领域的研发活动
    • 任务
      • 对生物製药发酵系统的认识有限且训练有素的专家
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物製药发酵系统市场：副产品

  • 下游加工产品
    • 层析法系统
    • 耗材及配件
    • 过滤/分离设备
  • 上游製程产品
    • 反应器或发酵罐
    • 缓衝
    • 媒体和文化准备
    • 过程监控系统

第七章生物製药发酵系统市场：依应用分类

  • 抗生素
  • 单株抗体
  • 益生菌
  • 重组蛋白

第八章生物製药发酵系统市场：依最终用户分类

  • 生物製药公司
  • 合约调查机构
  • 食品工业
  • 研发机构

第九章美洲生物製药发酵系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太生物製药发酵系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲生物製药发酵系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • AntoXa Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioPharm Process Associates, LLC
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • GEA Group Aktiengesellschaft
  • General Electric Company
  • Lonza Group
  • Merck KGaA
  • Nova Biomedical Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • ZETA GmbH
Product Code: MRR-437D45957C17

The Biopharmaceutical Fermentation System Market was valued at USD 15.65 billion in 2023, expected to reach USD 16.86 billion in 2024, and is projected to grow at a CAGR of 7.82%, to USD 26.52 billion by 2030.

The biopharmaceutical fermentation system market encompasses technologies and equipment used in the production of biopharmaceuticals, primarily through microbial and cell-based fermentation processes. These systems are essential for the large-scale production of biologics, including vaccines, monoclonal antibodies, and recombinant proteins, by facilitating controlled microbial growth. The necessity of fermentation systems is underscored by their critical role in producing complex, biologically active products that cannot be synthesized chemically. Applications include pharmaceuticals, biotechnology, food & beverages, and the environment, with end-users spanning from pharmaceutical companies to contract manufacturing organizations and research institutes. Key growth factors influencing this market include the rising demand for biopharmaceuticals due to increasing instances of chronic diseases and a growing focus on personalized medicine. Technological advancements in bioprocessing equipment, along with innovations in single-use systems, have also propelled market growth by offering more flexible, cost-effective, and scalable solutions. The latest potential opportunities lie in emerging markets with growing healthcare infrastructures and in the development of novel biosimilars and biologics. However, challenges such as high initial capital investment, stringent regulatory requirements, and complex manufacturing processes pose significant limitations to market expansion. Areas ripe for innovation include the development of efficient downstream processing techniques, improvements in process analytical technologies (PAT), and advancements in biologic production efficiency through synthetic biology. Research into automation and digitalization within fermentation processes also offers pathways for business growth. The market is dynamic, characterized by rapid technological advancements and a competitive landscape with key players investing heavily in R&D. Businesses can capitalize on these trends by focusing on developing more sustainable and efficient fermentation processes, thereby aligning with the industry's shift toward more eco-friendly biomanufacturing practices.

KEY MARKET STATISTICS
Base Year [2023] USD 15.65 billion
Estimated Year [2024] USD 16.86 billion
Forecast Year [2030] USD 26.52 billion
CAGR (%) 7.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Fermentation System Market

The Biopharmaceutical Fermentation System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for biotech based drugs
    • Increasing incidences of chronic diseases
    • Development in industrial measurement and monitoring technologies for bio-based production processes
  • Market Restraints
    • High cost related with the manufacturing and stringent regulatory requirements
  • Market Opportunities
    • New innovations to make efficient and cost-effective fermentation systems
    • Increasing research and developmental activities in different fields of fermentation technology
  • Market Challenges
    • Limited awareness and trained professionals in the field for biopharmaceutical fermentation systems

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Fermentation System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Fermentation System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Fermentation System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Fermentation System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Fermentation System Market

A detailed market share analysis in the Biopharmaceutical Fermentation System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Fermentation System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Fermentation System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Fermentation System Market

A strategic analysis of the Biopharmaceutical Fermentation System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Fermentation System Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AntoXa Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioPharm Process Associates, LLC, Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche AG, GEA Group Aktiengesellschaft, General Electric Company, Lonza Group, Merck KGaA, Nova Biomedical Corporation, Sartorius AG, Thermo Fisher Scientific Inc., and ZETA GmbH.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Fermentation System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Downstream Process Product and Upstream Process Product. The Downstream Process Product is further studied across Chromatography Systems, Consumables & Accessories, and Filtration & Separation Instruments. The Upstream Process Product is further studied across Bioreactors or Fermenters, Buffers, Media & Culture Preparation, and Process Monitoring Systems.
  • Based on Application, market is studied across Antibiotics, Monoclonal Antibodies, Probiotics, and Recombinant Proteins.
  • Based on End User, market is studied across Biopharmaceutical Companies, Contract Research Organizations, Food Industry, and Research & Development Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for biotech based drugs
      • 5.1.1.2. Increasing incidences of chronic diseases
      • 5.1.1.3. Development in industrial measurement and monitoring technologies for bio-based production processes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost related with the manufacturing and stringent regulatory requirements
    • 5.1.3. Opportunities
      • 5.1.3.1. New innovations to make efficient and cost-effective fermentation systems
      • 5.1.3.2. Increasing research and developmental activities in different fields of fermentation technology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and trained professionals in the field for biopharmaceutical fermentation systems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceutical Fermentation System Market, by Product

  • 6.1. Introduction
  • 6.2. Downstream Process Product
    • 6.2.1. Chromatography Systems
    • 6.2.2. Consumables & Accessories
    • 6.2.3. Filtration & Separation Instruments
  • 6.3. Upstream Process Product
    • 6.3.1. Bioreactors or Fermenters
    • 6.3.2. Buffers
    • 6.3.3. Media & Culture Preparation
    • 6.3.4. Process Monitoring Systems

7. Biopharmaceutical Fermentation System Market, by Application

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Monoclonal Antibodies
  • 7.4. Probiotics
  • 7.5. Recombinant Proteins

8. Biopharmaceutical Fermentation System Market, by End User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Contract Research Organizations
  • 8.4. Food Industry
  • 8.5. Research & Development Institutes

9. Americas Biopharmaceutical Fermentation System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopharmaceutical Fermentation System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceutical Fermentation System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. AntoXa Corporation
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioPharm Process Associates, LLC
  • 6. Danaher Corporation
  • 7. Eppendorf SE
  • 8. F. Hoffmann-La Roche AG
  • 9. GEA Group Aktiengesellschaft
  • 10. General Electric Company
  • 11. Lonza Group
  • 12. Merck KGaA
  • 13. Nova Biomedical Corporation
  • 14. Sartorius AG
  • 15. Thermo Fisher Scientific Inc.
  • 16. ZETA GmbH

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FILTRATION & SEPARATION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOREACTORS OR FERMENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MEDIA & CULTURE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROCESS MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RESEARCH & DEVELOPMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023